Nitroxide Antioxidant Modulation of Apoptosis Gene Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments fail to effectively address dysregulation in the apoptosis pathway, leading to various diseases such as cancers, autoimmune diseases, and neurodegenerative disorders, as they do not adequately manage increased or decreased levels of apoptosis, which are associated with gene expression alterations.
Innovation Solution
Administering an effective amount of a nitroxide antioxidant, specifically 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl, to reduce the expression level of genes associated with the apoptosis pathway in tissues like skin, immune, pancreatic, and neuronal tissues, thereby treating or preventing diseases related to abnormal apoptosis levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments are used to address apoptosis pathway dysregulation, then disease symptoms may be temporarily managed, but the underlying increased or decreased levels of apoptosis and associated gene expression alterations remain unaddressed, leading to disease progression
Solution Approach 1:
The patent applies parameter changes by using a nitroxide antioxidant to alter the expression levels of apoptosis-related genes. The treatment modifies the biochemical parameters of the apoptosis pathway by reducing the expression of pro-apoptotic genes (such as Bak1, Pdcd5, Casp2, Tradd, Tp53inp1, and Casp3) through antioxidant activity, thereby restoring balanced apoptosis levels and treating multiple apoptosis-related diseases with a single mechanism-based approach
2Object-affected harmful factors
If apoptosis levels are increased to eliminate damaged cells, then cancer prevention may be improved, but autoimmune diseases and inflammatory conditions worsen due to excessive cell death
Solution Approach 1:
The patent converts the harmful effect of unbalanced apoptosis into a beneficial outcome by using nitroxide antioxidants to modulate apoptosis-related gene expression. The antioxidant transforms the pathological apoptosis process into a controlled therapeutic effect, reducing expression of pro-apoptotic genes to achieve balanced cell death levels that prevent both cancer and autoimmune diseases simultaneously
3Reliability
If gene expression of apoptosis pathway is reduced to prevent excessive cell death, then neurodegenerative diseases may be prevented, but immune response to infections could be compromised
Solution Approach 1:
The patent applies local quality by selectively reducing the expression of specific pro-apoptotic genes (Bak1, Pdcd5, Casp2, Tradd, Tp53inp1, Casp3) in affected tissues such as neuronal tissues for neurodegenerative diseases, while maintaining normal apoptosis function in immune tissues to preserve immune response efficiency. The nitroxide antioxidant achieves tissue-specific modulation of apoptosis gene expression based on local pathological needs
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nitroxide antioxidant effectively reduces the expression levels of genes like Bak1, Pdcd5, Casp2, Tradd, Tp53inp1, and Casp3, counteracting increased apoptosis and associated diseases, including neurodegenerative disorders, autoimmune diseases, and immune system dysfunctions, thereby ameliorating or preventing disease progression.
Implementation Method 1
administering to the individual an effective amount of a nitroxide antioxidant to reduce the level of expression of the gene associated with the apoptosis pathway
Data Source
AI summary
Disclosed herein are methods for treating a human subject having a disease associated with an increased level of apoptosis using a nitroxide. Further disclosed are methods for treating a human subject in need of a reduced expression level of a gene associated with the apoptosis pathway using a nitroxide.